features: Immuno-Oncology

The U.S Food and Drug Administration (FDA) has granted priority review for the fixed-dose combination of relatlimab, a LAG-3 targeting…

Check out our top picks from ESMO 2021!

Highlights from ASCO 2021 in lung cancer! Learn more about the major clinical trials reported at this year’s meeting.

VJOncology presents highlights from this year’sEuropean Association of Urology (EAU) Virtual Meeting 2021!

VJOncology brings you highlights in GI cancer from this year’s virtual American Society of Clinical Oncology (ASCO) annual meeting!

VJOncology presents highlights from this year’s virtual American Society of Clinical Oncology (ASCO) annual meeting!

The Food and Drug Administration (FDA) granted accelerated approval to dostarlimab on April 2021 for patients with recurrent or advanced…

VJOncology presents highlights from this year’s virtual European Society for Medical Oncology (ESMO) Breast Cancer Congress!

VJOncology are excited to present some key abstracts and trial updates announced at this year’s virtual St. Gallen Breast Cancer…

In a nationwide effort to prioritize and accelerate translational research, a brand-new oncology research collaboration has been established by The…

VJOncology are pleased to bring you our top picks from the recent virtual WCLC meeting

EPIC-OPC study: misclassification of OPC patients The presence of human papillomavirus p16 alone is not sufficient to classify oropharyngeal cancer…

Immune checkpoint inhibitors have shown promising therapeutic outcomes in many types of cancer, but ovarian cancer has been an exception….